396MO Anti-claudin 18.2 (CLDN18.2) antibody-drug conjugate (ADC) IBI343 in patients (pts) with solid tumors and gastric/gastro-esophageal junction adenocarcinoma (G/GEJ AC): A phase I study

Jing Liu, Xiang Yu, Jianguo Zhang, Jin‐Kui Yang, Junqiu Yue, Yongwei Sun, Yan Pan, Mei Sun, Y Qin, Lan Shen, Ruixia Song, Jue Ruan, A. Zhou, Yun Mou, Zhihong Liu, Zhihong Liu, M. D. Morris, Morteza Aghmesheh, Andrea Tazbirkova, Hong‐Hao Zhou